Hims & Hers Health, Inc. Overview
Pro stress-test →Hims & Hers Health operates a telehealth platform that connects consumers to licensed healthcare professionals, offering a range of curated prescription and non-prescription health and wellness products and services through websites and mobile applications. The company addresses growing demand for accessible digital healthcare across multiple specialties including mental health, sexual health, dermatology, and weight loss management.
Strategic Profile
Pro stress-test →Hims & Hers has expanded beyond its core telehealth business through geographic expansion into the UK and Canada, new product launches, and strategic acquisitions. However, the company faces significant challenges from a Novo Nordisk lawsuit over compounded semaglutide products and DOJ scrutiny, which could impact future growth and compliance efforts.
Competitive Landscape
Pro stress-test →Novo Nordisk's official Wegovy partners include CVS Health, Costco, LifeMD and GoodRx, with Hims notably absent from the list. This likely reflects disagreements over Hims' compounded semaglutide strategy, with the broader rollout of Wegovy pills putting pressure on Hims' GLP-1 business. Hims competes in the crowded telehealth and digital health space against established players and GLP-1 manufacturers.
Industry Context
Hims & Hers Health, Inc. operates in Digital Health / Telehealth.
Key facts
Founded: 2017 · Headquarters: San Francisco, US · Employees: 1,640 · Revenue: $2.4B · Market cap: $3.5B